Patents by Inventor Roberto Correa

Roberto Correa has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Immunogenic peptides of foot-and-mouth disease viruses
    Patent number: 6984387
    Abstract: The present invention relates to FMDC vaccine based on peptides having a sequence of at least 8 amino acids, which corresponds to a partial sequence of the non-structural protein region of FMDV, which was selected by immunoreactivity with FMDV-specific antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their production and their use.
    Type: Grant
    Filed: September 8, 1997
    Date of Patent: January 10, 2006
    Assignee: Bayer Aktiengesellschaft
    Inventors: Roberto Correa, Hans-Robert Hehnen, Eberhard Pfaff, Armin Saalmüller, Thomas Pauly, Bettina Höhlich, Bernadette Glatthaar-Saalmüller, Karl-Heinz Wiesmüller
  • Immunogenic peptides of foot-and-mouth disease viruses
    Publication number: 20050058656
    Abstract: The present invention relates to FMDC vaccine based on peptides having a sequence of at least 8 amino acids, which corresponds to a partial sequence of the non-structural protein region of FMDV, which was selected by immunoreactivity with FMDV-specific antibodies or by immunoreactivity with FMDV-specific T lymphocytes, and to their production and their use.
    Type: Application
    Filed: November 9, 2004
    Publication date: March 17, 2005
    Applicant: Bayer Aktiengesellschaft
    Inventors: Roberto Correa, Hans-Robert Hehnen, Eberhard Pfaff, Armin Saalmuller, Thomas Pauly, Bettina Hohlich, Bernadette Glatthaar-Saalmuller, Karl-Heinz Wiesmuller
  • Method for the analytical separation of viruses
    Patent number: 5723031
    Abstract: The method permits the non-destructive analytical detection and/or the quantification of viruses or viral particles (analytes) in a liquid sample matrix containing organic or inorganic minor constituents, in particular protein moieties and/or nucleotides and/or other viruses. To this end the viruses or the viral particles are separated from the protein moieties and/or nucleotides in the sample matrix using capillary electrophoresis and at the same time the electropherogram associated therewith is recorded. The fractions assigned to the analytes can then be identified as virus peaks in the electropherogram by spectroscopic interpretation with the aid of characteristic maxima. For better identification, a reference sample of a known virus or of a known viral particle can be added to the sample matrix.
    Type: Grant
    Filed: October 24, 1995
    Date of Patent: March 3, 1998
    Assignee: Bayer Aktiengesellschaft
    Inventors: Hansjorg Durr, Hans-Robert Hehnen, Lothar Helbig, Roberto Correa, Ulf Bruggemeier